Table: Brightpath Biotherapeutics -2019/20 parent forecast

BrightPath Biotherapeutics Co

17/01/2020 06:00

Jan 17 (Reuters) -
              Brightpath Biotherapeutics Co., Ltd.     
              PARENT- ONLY EARNINGS ESTIMATES
  (in billions of yen unless specified)                    
                 Full Year to      Full Year to 
               Mar 31, 2020      Mar 31, 2020   
                  LATEST           PREVIOUS     
                 FORECAST          FORECAST     
  Sales           11 mln             4 mln      
  Operating      loss 2.42         loss 2.42    
  Recurring      loss 2.42         loss 2.42    
  Net            loss 2.44         loss 2.44    
  EPS         loss 57.89 yen    loss 58.03 yen  
 
  NOTE - Brightpath Biotherapeutics Co., Ltd..    
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4594.T